NCPA: Mergers, market manipulation fuel rise in generic-drug prices
Generic drugs are inexpensive when there is competition, but less so when conditions on the supply side of the generic-drug market hamper competition, which is exactly what’s happening in the wholesale drug industry, Devon Herrick, senior fellow at the National Center for Policy Analysis, said. Read More »